The interaction of metabolic factors with HCV infection: Does it matter?
References (121)
Evolving epidemiology of hepatitis C virus
Clin Microbiol Infect
(2011)- et al.
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection
Gastroenterology
(2011) - et al.
The metabolic syndrome-a new worldwide definition
Lancet
(2005) - et al.
Hepatitis C virus infection and incident type 2 diabetes
Hepatology
(2003) - et al.
The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C
Am J Transplant
(2006) - et al.
Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression
Gastroenterology
(2003) - et al.
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
Gastroenterology
(2008) - et al.
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C
J Hepatol
(2008) - et al.
Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance
Gastroenterology
(2004) - et al.
Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus
Best Pract Res Clin Endocrinol Metab
(2007)
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
J Biol Chem
(2002)
Cellular mechanisms of insulin resistance: role of stressregulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation
Curr Opin Pharmacol
(2009)
Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes
Hepatology
(2003)
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3
Am J Pathol
(2004)
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signaling in chronic hepatitis C
J Hepatol
(2008)
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C
J Hepatol
(2011)
Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression
J Biol Chem
(2008)
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice
J Biol Chem
(2001)
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity
J Hepatol
(1999)
Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association
Am J Gastroenterol
(2003)
Molecular diagnosis of hypobetalipoproteinemia: an ENID review
Atherosclerosis
(2007)
Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES lll]
Diabetes Res Clin Pract
(2007)
Host- and disease-specific factors affecting steatosis in chronic hepatitis C
J Hepatol
(1998)
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
J Hepatol
(2000)
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
Hepatology
(2001)
Hepatitis C virus genotype 3 is cytopathic to hepatocytes. Genotype-specific reversal of hepatic steatosis after sustained response to antiviral therapy
Hepatology
(2002)
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C
Hepatology
(2003)
An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation
J Hepatol
(2005)
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus
Gastroenterology
(2002)
Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis
J Hepatol
(2008)
Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity
Hepatology
(2002)
Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core
J Hepatol
(2007)
Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice
J Biol Chem
(2009)
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
J Hepatol
(2001)
Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a
Am J Gastroenterol
(2002)
Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis
Gastroenterology
(2006)
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection
Gastroenterology
(2005)
Viral genotype-specific effect of PNPLA3, PPARG, IL28B and MTTP on hepatitis C virus-associated steatosis
J Hepatol
(2011)
Hepatitis B and C virus infection and the risk of atherosclerosis in a general population
Atherosclerosis
(2004)
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C
J Hepatol
(2007)
HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques
Dig Liver Dis
(2007)
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan
Gastroenterology
(2008)
Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis
J Hepatol
(2010)
Global and societal implications of the diabetes epidemic
Nature
(2001)
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression
Gastroenterology
(2010)
Current understanding of insulin resistance in hepatitis C
Expert Rev Gastroenterol Hepatol
(2011)
Abnormalities of lipid metabolism in hepatitis C virus infection
Gut
(2010)
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
JAMA
(2001)
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
Circulation
(2009)
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States
Ann Intern Med
(2000)
Cited by (159)
Fatty Liver Disease
2023, MacSween's Pathology of the Liver, Eighth EditionResidual risk of liver disease after hepatitis C virus eradication
2021, Journal of HepatologyHepatitis C virus associated hepatocellular carcinoma
2021, Advances in Cancer ResearchExtrahepatic Manifestations of Chronic Viral C Hepatitis
2020, Gastroenterology Clinics of North AmericaThe Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
2023, Reviews in Cardiovascular Medicine
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. All rights reserved.